Modeling the Cost and Health Impacts of Diagnostic Strategies in Patients with Suspected Transthyretin Cardiac Amyloidosis.

Ge, Yin; Pandya, Ankur; Cuddy, Sarah A M; Singh, Amitoj; Singh, Avinainder; Dorbala, Sharmila

Ge, Yin; Pandya, Ankur; Cuddy, Sarah A M; Singh, Amitoj; Singh, Avinainder; Dorbala, Sharmila.

Afiliación

Ge Y; Division of Cardiology, Department of Medicine St. Michael's Hospital, University of Toronto Toronto Canada.
Pandya A; Department of Health Policy and Management Harvard T.H. Chan School of Public Health Boston MA.
Cuddy SAM; Amyloidosis Program, Division of Cardiology, Department of Medicine Brigham and Women's Hospital Boston MA.
Singh A; CV Imaging Program, Cardiovascular Division and Department of Radiology Brigham and Women's Hospital Boston MA.
Singh A; Sarver Heart Center, Division of Cardiology, Department of Medicine University of Arizona, Tucson (Banner University Medical Center) Tucson AZ.
Dorbala S; Cardiovascular Division, Department of Medicine Brigham and Women's Hospital Boston MA.

J Am Heart Assoc ; 11(18): e026308, 2022 09 20.

Article en En | MEDLINE | ID: mdl-36102240

Asunto(s)

Amiloidosis; Cardiomiopatías; Insuficiencia Cardíaca; Humanos; Difosfatos; Prealbúmina; Tecnecio

Palabras clave

cardiac amyloidosis; costbenefit analysis; multimodal imaging

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Insuficiencia Cardíaca / Amiloidosis / Cardiomiopatías Tipo de estudio: Diagnostic_studies / Health_economic_evaluation / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: J Am Heart Assoc Año: 2022 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google